India Challenges Pfizer to Perform Clinical Trial on Its Covid Vaccine, Pfizer Drops Out

Research scientist, Pixabay
image_pdfimage_print


Pfizer has withdrawn an application for emergency-use authorization of its COVID-19 vaccine after India asked for a small, local trial on the vaccine’s safety. Indian health officials say they generally ask for these trials to determine if a vaccine is safe and if it generates an immune response in its own citizens, whose genetic makeup can be different from people in Western nations. Two other vaccines – from AstraZeneca and Bharat Biotech – have been approved. Pfizer claims that its application was supported by data from a global study that showed an overall efficacy rate of 95% with no vaccine-related, serious safety concerns – but they were not willing to allow a new trial to prove it. -GEG

Pfizer Inc has withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India that it has developed with Germany’s BioNTech, the company told the Reuters news agency on Friday.

The United States company, which was the first drugmaker to apply for emergency use authorisation of its COVID-19 vaccine in India, had a meeting with the country’s drugs regulator on Wednesday and the decision was made after that, the company said.

Read full article here…

Visit our Classified ads.

Check out our Classified ads at the bottom of this page.

Recent stories & commentary

No Picture
Health

CDC Calls “Emergency Meeting” After Reports of Heart Inflammation Following Vaccination. Germany Advises Against Covid Shots in Young People.

The CDC has called for an “emergency meeting” following 573 reports of myocarditis inflammation of the heart in people vaccinated with the Pfizer or Moderna vaccines. The CDC recently said it would launch an investigation into a link between the vaccine and several cases of heart inflammation in vaccinated adolescents.

Money

In a World First, El Salvador Makes Bitcoin Legal Tender

El Salvador’s legislature voted this week to accept Bitcoin as legal tender alongside the US dollar, which is the country’s official currency. Critics say that El Salvador’s acceptance of a competing currency is a hedge against the US dollar that has massively increased its money supply, which will cause inflation.

Classifieds

For classified advertising rates and terms, click here. The appearance of ads on this site does not signify endorsement by the publisher. We do not attempt to verify the accuracy of statements made therein or vouch for the integrity of advertisers. However, we will investigate complaints from readers and remove any message we find to be misleading or that promotes anything fraudulent, illegal, or unethical.

Subscribe
Notify of
guest
1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Questionit21
Questionit21
3 months ago

If Pfizer so called Vaccine for Covid 19 has 95% safe and effective rate then would not matter which Country wants to run their own clinical trial because the results will be the same. India being refused to run its own clinical trial brings up an important point did Pfizer indeed have a 95% safe and effective rate and is it a true Vaccine or Genetic Manipulation that is going to cause potentially millions of serious side effects and deaths in the months or maybe years to follow. Where all mRNA Vaccine Manufacturers can be put under the Vaccine umbrella… Read more »